Cigna Group (NYSE:CI) Cut to Hold at Wall Street Zen

Cigna Group (NYSE:CI) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

Other research analysts have also recently issued reports about the stock. Truist Financial increased their target price on shares of Cigna Group from $310.00 to $320.00 and gave the company a “buy” rating in a report on Monday, January 5th. Jefferies Financial Group reaffirmed a “buy” rating and set a $310.00 price objective on shares of Cigna Group in a report on Monday, November 3rd. Guggenheim reiterated a “buy” rating and set a $318.00 target price on shares of Cigna Group in a research report on Tuesday, December 2nd. Wolfe Research dropped their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. Finally, Mizuho set a $325.00 price objective on shares of Cigna Group in a research report on Friday, January 9th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $330.36.

Cigna Group Trading Down 0.4%

Shares of CI stock opened at $279.31 on Friday. The business’s fifty day moving average price is $274.46 and its 200 day moving average price is $285.81. The firm has a market capitalization of $74.61 billion, a PE ratio of 12.32, a P/E/G ratio of 0.99 and a beta of 0.26. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same quarter last year, the company earned $7.51 earnings per share. Cigna Group’s quarterly revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani purchased 4,134 shares of the stock in a transaction on Monday, November 3rd. The stock was bought at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.70% of the company’s stock.

Institutional Trading of Cigna Group

Institutional investors have recently modified their holdings of the company. Solstein Capital LLC acquired a new position in shares of Cigna Group in the second quarter worth about $29,000. Harbor Capital Advisors Inc. raised its position in shares of Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares in the last quarter. Chilton Capital Management LLC purchased a new position in shares of Cigna Group during the 2nd quarter valued at approximately $30,000. Princeton Global Asset Management LLC grew its position in shares of Cigna Group by 115.6% during the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock worth $32,000 after buying an additional 52 shares in the last quarter. Finally, Beacon Financial Strategies CORP acquired a new stake in shares of Cigna Group during the fourth quarter worth approximately $28,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.